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Abstract Liquid chromatography coupled to mass spec-
trometry nowadays plays an important role in the field of
therapeutic drug monitoring (TDM), especially of new
compounds for which no immunoassays are available. This
paper reviews LC–MS(–MS) methods published recently
for anti-infective drugs: antiretroviral drugs, other antiviral
drugs, antibacterial drugs, antihelmintic drugs, antimalarial
drugs, and other antiprotozoal drugs. An overview of the
different methods is given, with special focus on selection
of the internal standard and validation procedures.
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Introduction
LC–MS(–MS) nowadays plays a major role in the field of
therapeutic drug monitoring (TDM). The number of instru-
ments available in clinical laboratories is increasing
tremendously and a large number of methods have been
published in recent years. Nevertheless, most of the drug
concentration measurements performed for clinical purpo-
ses are determined by immunoassays. Because only few
immunoassays for TDM have been developed in the last
20 years, for the quantification of drugs introduced in this
period chromatographic methods have to be applied. When
HPLC coupled to mass spectrometry became more popular
in clinical laboratories, the advantage of a shorter run-time
compared with UV or fluorescence detection, increased
specificity, and the higher sensitivity led to the application
of LC–MS(–MS) instruments all over the world.
Because of these advantages, the drugs most often
analysed by LC–MS(–MS) in clinical laboratories belong
to the drug classes immunosuppressants, antidepressants,
antipsychotics, or antiretroviral compounds. Saint-Marcoux
et al. [1] published, in 2007 a very comprehensive review
on the current role of LC–MS(–MS) in TDM focusing
mainly on immunosuppressants, antifungal drugs, antire-
troviral drugs, antidepressants, and antipsychotics. In this
review we will focus on drugs with anti-infective activities,
mainly antiviral drugs (including an update on antiretroviral
drugs), antibacterial drugs, antihelmintic drugs, and anti-
protozoal drugs. With the exception of the aminoglycosides
and glycopeptides, the need for TDM is still discussed
controversially for all of these compounds. Nevertheless
there are many clinical situations which make the quanti-
fication of these drugs necessary, e.g. patients on haemofil-
tration, pharmacokinetic interactions, or pharmacogenetic
questions.
Internal standards are widely used for quantitative LC–
MS(–MS) methods, because they can compensate for
variability during sample preparation and, optimally, also
for fluctuations in the ionisation efficiency. The optimum
internal standard would have chemical and physical
properties very similar to those of the drug of interest
during the entire process of sample preparation and LC–MS
(–MS) analysis. This gives rise to the conclusion that stable
isotope-labelled analogues of the analytes are the optimum
internal standards. In recent years however it has become
clear that these stable isotope-labelled drug analogues may
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lead to ion suppression and their use must, therefore, be
carefully validated [2].
Also, in general, all authors should validate their
methods according to conventional validation guidelines
(e.g. FDA, EMEA) and manuscript reviewers should also
focus on complete validation including ion suppression
analysis in LC–MS(–MS) methods.
For this review we have searched the literature since
2000 for antiviral drugs, antibacterial drugs, antihelmintic
drugs, and antiprotozoal drugs. As TDM of antiretroviral
drugs in plasma by LC–MS(–MS) were reviewed in 2007
[1], we only included articles concerning quantification in
plasma published since 2007 for our article. Nevertheless,
the number of papers published for this drug class is by far
the highest. Special emphasis is put on the selection of




The need for TDM in highly active antiretroviral therapy is
still discussed controversially. There are many laboratories
in developed countries which measure the concentrations of
the protease inhibitors (PIs) and non-nucleoside reverse
transcriptase inhibitors (NNRTIs) regularly for their
patients and physicians guide the dose according to the
measured drug concentrations. Nevertheless, scientific
evidence of the need for TDM is still missing, which has
also been concluded by Kredo et al. in their review for the
Cochrane library [3]. In addition to TDM for guidance of
therapy for all patients, there are other indications for the
measurement of concentrations of antiretroviral drugs.
Some of these indications are pharmacokinetic interactions,
testing for compliance, treatment of viruses with resistance
genes, or pregnant patients. Since 2007, sixteen papers have
been published describing quantitative analyses of PIs and
NNRTIs in serum, plasma, or hair [4–19] using LC–MS(–
MS). Nucleoside reverse transcriptase inhibitors (NRTIs)
do not exert any pharmacokinetic interactions, but their
concentrations are still helpful for checking compliance or
treating patients infected with viruses having resistance
genes. These drugs need to be activated intracellularly
(namely phosphorylated) which then gives the rationale for
quantification of the active metabolites of these compounds
in peripheral blood mononuclear cells (PBMCs). Since
2000, 14 papers have been published describing quantifi-
cation of the metabolites of NRTIs or the intracellular
concentrations of PIs and NNRTIs by LC–MS–MS in
PBMCs [5, 14, 20–31]. Very recently a method has been
described which enables the concomitant quantification of
intracellular natural and antiretroviral nucleosides and
nucleotides in PBMCs [32]. The method has not been
applied in the context of TDM but for cell-culture assays
and should be adaptable for TDM in patient samples. In
addition, six papers have been presented describing the
quantification of the parent compounds of NRTIs in serum
or plasma [33–38]. In the time period considered for this
review most of the methods were using tandem mass
spectrometry as detection method for quantification of
antiretroviral drugs. An overview on these methods can be
seen in Table 1. Several authors described methods using
UV detection, mainly focusing on laboratories which
cannot afford a very expensive mass spectrometer [39–44].
PIs and NNRTIs usually were quantified with LC–MS(–
MS) methods enabling the simultaneous quantification of
several drugs. Nevertheless, in the last three years six
papers have been published describing the determination of
only one substance, namely lopinavir [4], raltegravir [5–8]
or saquinavir [9]. In all these methods different sample-
preparation techniques were applied including online
sample clean-up [8]. Most of the authors used isotope-
labelled analogues of the compound or another structural
analogue, except ter Heine et al. [5]. In this paper
dibenzepine was used as internal standard. Unfortunately,
few authors included ion suppression or matrix effects in
their validation procedures [5, 6, 8, 9]. Chromatography
was always performed using a C18 column, except the
method described by Wagner et al. [9] which did not use
chromatography but applied the extracted sample directly to
a MALDI (matrix assisted laser desorption ionisation)
target. Detection has always been performed by selected
reaction monitoring (SRM) on triple-stage quadrupole
instruments after, mostly, electrospray ionisation. Only
Difrancesco et al. and Merschmann et al. used atmospheric
pressure chemical ionisation (APCI), which has shown to
be less prone to ion suppression.
Fayet et al. [10] published, in 2009, the first multianalyte
procedure also including two substances of new antiretro-
viral drug classes—raltegravir, an integrase inhibitor, and
maraviroc, a CCR5 antagonist. Darunavir and etravirine
were the other two compounds included in the method.
Separation was performed on a C18 column with a mobile
phase consisting of aqueous ammonium acetate, formic
acid and acetonitrile with a run time of 20 min. The
analytical range for all the compounds was 0.0025–10 mg
L−1.
In the last three years four papers have been published
describing the quantification of lopinavir and ritonavir [11–
14], which are always given to patients concomitantly. The
sample volume needed for the different methods varies
between 25 μL [14] and 200 μL plasma [13] and sample
preparation has been performed by solid-phase extraction
(SPE) [11], liquid–liquid extraction (LLE) [13], and protein
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precipitation (PP) [12, 14]. All internal standards used were
either deuterated analogues of a PI or a structural analogue.
ESI was always used, and detection by SRM on a triple
stage quadrupole. The method described by Estrela et al.
[13] not only used plasma as sample material but was also
validated for ultrafiltered plasma, semen, and saliva, always
using 200 μL. The lower limits of quantification were
0.001 mgL−1 for lopinavir and ritonavir, irrespective of the
sample material. The upper limits of quantification were
2.0 mgL−1 for lopinavir in plasma, 0.2 mgL−1 for lopinavir
in semen and ultrafiltered plasma, and 0.1 mgL−1 for saliva.
For ritonavir the values were 0.2 mgL−1 for plasma and
0.05 mgL−1 for semen, saliva, and ultrafiltered plasma.
Ehrhardt et al. [14] presented a method using 25 μL
plasma, 500 μL ultrafiltered plasma, or PBMCs harvested
from 8 mL peripheral blood. The analytical range for both
analytes in plasma was 0.004–10 mgL−1; the respective
value for ultrafiltered plasma was 0.20–500 μgL−1 and the
analytical range in PBMCs was 0.10–250 ng per 3×106
cells.
Since 2007, three papers have been published describing
the simultaneous quantification of up to five different PIs
and NNRTIs [15, 16, 28]. Huang et al. [15] described the
quantification of efavirenz, lopinavir, and ritonavir in
human hair, with the purpose of using a sample material
which enables monitoring of long-term drug exposure over
a period of weeks to months. Whereas ritonavir-d6 was
used as internal standard for quantification of lopinavir and
ritonavir, they used celecoxib as internal standard for the
quantification of efavirenz; celecoxib has no structural
similarity to efavirenz.
In the last three years, seven papers have been published
describing the simultaneous quantification of nine to
seventeen antiretroviral drugs simultaneously either in
plasma [17–19, 44] or in PBMCs [29–31]. The plasma
methods included amprenavir, atazanavir, efavirenz, indi-
navir, lopinavir, nelfinavir (some also its metabolite M8),
nevirapine, ritonavir, and saquinavir. D’Avolio et al. [17]
and ter Heine et al. [18] included also the newest PIs
darunavir and tipranavir in their procedures, whereas Jung
et al. [19] included some of the NRTIs (abacavir,
didanosine, lamivudine, stavudine, zalcitabine, tenofovir,
and delavirdine) in their method. D’Avolio et al. [17] and
ter Heine et al. [18] used protein precipitation as sample-
preparation method with a similar analytical range but very
different run times of 10 min [18] versus 25 min [17]. The
method described by Jung et al. [19] used liquid–liquid
extraction combined with protein precipitation with a run
time of 18 min but a much lower analytical range compared
with the other methods, which will not even allow
measurement of trough concentrations in patients for all
compounds. The internal standards used in these three
multi-analyte procedures included quinoxaline [17], cimet-
idine [18], and deuterated analogues of efavirenz, indinavir,
saquinavir , and dibenzepine [19]. Gehrig et al. [44] used
protein precipitation for sample preparation and included
also delavirdine as NNRTI and 2 NRTIs (zalcitabine,
zidovudine) for quantification. In addition they also
detected six NRTIs (abacavir, didanosine, emtricitabine,
lamivudin, stavudine, and tenofovir). The run time was
only 10 min, and the analytical range was comparable with
those of the other multianalyte procedures.
Since 2000, several methods have been published
describing the intracellular concentrations of antiretroviral
drugs. The cells which have been used for these quantifi-
cations are always PBMCs which are thought to be the
target of the different antiretroviral drugs. PBMCs have
been used as sample materials for analysis of amprenavir,
efavirenz, indinavir, lopinavir, nelfinavir (some also its
metabolite M8), nevirapine, and ritonavir. Pelerin et al. [29]
also included saquinavir and delavirdine in their procedure,
Colombo et al. [30] also determined atazanavir and
saquinavir and Elens et al. [31] atazanavir, saquinavir, and
tipranavir. Sample preparation consisted always of cell
lysis; Colombo et al. [30] and Elens et al. [31] extracted the
lysed cells for 3 h or overnight on a horizontal shaker. Only
Elens et al. [31] selected internal standards with structural
similarities to the compounds to be analysed. The method
described by Colombo et al. [30] used clozapine as internal
standard whereas Pelerin et al. [29] used ketoconazole. It
must, however, be mentioned that these two methods were
published in 2005; at that time deuterated analogues of the
PIs and NNRTIs were not commercially available. The
analytical ranges can hardly be compared as Pelerin et al.
[29] described a calibration per sample, namely the total
extracted amount of the different drugs out of 7 mL blood.
Colombo et al. [30] and Elens et al. [31] calibrated their
method according to the concentration of the different
drugs in the solution used to spike blank PBMCs.
As NRTIs have to be phosphorylated if they are to exert
their antiviral activity, measurements of the phosphorylated
metabolites of NRTIs in PBMCs are the optimum means of
measuring drug exposure. Therefore, most of the methods
published for the quantification of NRTIs use PBMCs as
sample material. These cells must be lysed after harvesting;
some of the authors then added an additional SPE [20, 22,
27] or immunoaffinity extraction [21] to their extraction
method. King et al. [20] described a method for specific
quantification of tenofovir diphosphate, using the deuterat-
ed analogue as the internal standard. The amount of blood
needed for isolation of PBMCs was 25 mL. Becher et al.
[21] and King et al. [22] described a quantitative method
for analysis of zidovudine triphosphate. Whereas Becher et
al. [21] used immunoaffinity extraction with PBMCs from
7 mL blood, King et al. [22] applied SPE with PBMCs out
of 26 mL blood. The run time of the ion-pair liquid
2580 D.M. Müller, K.M. Rentsch
chromatographic method described by Becher et al. [21]
was 26 min, which is more than twice as long as that
described by King et al [22]. Several methods have been
published describing the simultaneous analysis of different
NRTIs. Becher et al. [23] described a procedure for
simultaneous quantification of didanosine triphosphate and
stavudine triphosphate. They used PBMCs from 7 mL
blood and performed ion-pair liquid chromatography on a
reversed phase column. The run time of the second method
of this group was again relatively long—26 min. Compain
et al. [24] published a procedure for quantification of
stavudine triphosphate, zidovudine diphosphate, and zido-
vudine triphosphate in PBMCs. They also added dimethyl-
hexylamine as ion-pair reagent to the mobile phase and
were able to achieve a run time of 9.5 minutes. Pruvost et
al. [25] presented a method for quantification of carbovir
triphosphate, lamivudine triphosphate, and tenofovir tri-
phosphate using a comparable chromatographic approach.
Robbins et al. [27] described a procedure for quantification
of the same NRTIs using reversed-phase chromatography
after SPE of the lysed PBMCs. Both methods have a
similar analytical range and comparable run times of
approximately 15 min.
Other antiviral drugs
HPLC in combination with UV detection is often used for
TDM of other antiviral drugs, mostly in plasma [45–55] but
also in cerebrospinal fluid [56] and—for the same reasons
as antiretroviral drugs—intracellularly [57].
Regarding TDM using LC–MS(–MS), several new
methods have been published (Table 2). For determina-
tion of adefovir, which is mostly used for treatment of
chronic hepatitis B, five methods have been published
[58–62] since 2000. Most authors used protein precipita-
tion as sample pretreatment, except Liu et al. [61], who
used solid-phase extraction. Regarding the choice of the
internal standards, Liu et al. [61] applied the most
advanced approach with a 13C-labelled analogue of
adefovir. Bi et al. [59], even though reporting good
accuracy and precision, did not mention the use of an
internal standard at all, a procedure which, in our opinion,
can no longer be recommended.
Run times of all methods were comparable, with a range
from 7.8 [59] to 10 min [62]. In all methods, ESI was used
as ionization method, mainly in positive mode, only once
reported in negative mode by Liu et al. [61]. Regarding the
analytical range, Zou et al. [62] reported the most sensitive
method with a limit of quantification of 0.2 μgL−1.
Since 2000, three LC–MS(–MS) methods have been
published for quantification of entecavir and tenofovir, two
substances also used for the therapy of chronic hepatitis B.
For entecavir, Zhang et al. [63] published a method that
was applied to a Phase I clinical study. Using solid-phase
extraction of a relatively large sample volume (1 mL
plasma), a very low limit of quantification, 0.005 μgL−1,
could be achieved. For tenofovir, two LC–MS(–MS)
methods have been published. Yadav et al. [64] recently
presented a method with a run time of only 1.8 min using a
monolithic column, and solid-phase extraction as sample
pretreatment. The method of Delahunty et al. [65] had a run
time of 7 min, with protein precipitation in 250 μL plasma
as sample preparation.
Ribavirin is an important drug in the therapy of chronic
hepatitis C. A method for intracellular analysis of ribavirin
in red blood cells was presented by Yeh et al. [66], who
used 13C-labelled ribavirin as internal standard. Ribavirin
accumulates in red blood cells, which leads over time to
rupture of the cells, causing haemolytic anaemia, an
important side effect of treatment with this drug. Shou
et al. [67] and Zhou et al. [68] both reported a method using
protein precipitation in 0.1 mL plasma as sample prepara-
tion. Accuracy and precision reported by Shou et al. [67]
were slightly better than those reported by Zhou et al. [68],
whereas Zhou et al. [68] reported a lower limit of
quantification of 1 μgL−1, a factor of ten lower than the
10 μgL−1 of Shou et al. [67]. The upper limit of
quantification was 1 mgL−1 for both methods. Liu et al.
[69] presented a method for simultaneous quantification of
viramidine, a prodrug of ribavirin, and ribavirin in human
plasma, using the 13C-labelled analogues of both drugs as
internal standards. The analytical range was 0.001 to 1 mg
L−1 for both analytes.
For quantitative determination of cidofovir, a nucleotide
analogue which is approved for the therapy of CMV
retinitis in AIDS patients, Breddemann et al. [70] devel-
oped a method which was used for a pharmacokinetic study
in paediatric cancer patients. With solid-phase extraction of
0.3 mL serum, an analytical range from 0.0078–10 mgL−1
could be achieved.
For determination of penciclovir, valacyclovir, acyclovir,
and ganciclovir, a total of four LC–MS(–MS) methods have
been presented since 2000 [71–74]. Lee et al. [72]
published a method for a bioequivalence study, in which
protein precipitation in 250 μL of plasma led to an
analytical range of 0.05–10 mgL−1. The run time of the
method was quite short—2.4 min. Yadav et al. [74] and
Kasiari et al. [71] both presented methods for simultaneous
determination of valacylovir and acyclovir in human
plasma. Yadav et al. [74] used selected reaction monitoring
(SRM) with analytical ranges of 0.005 to 1.075 mgL−1 for
valacyclovir and if 0.0476 to 10.225 mgL−1 for acyclovir.
Kasiari et al. [71] applied single ion monitoring (SIM) with
an analytical range from 0.02 to 0.8 mgL−1 for valacyclovir
and 0.1 to 20 mgL−1 for acyclovir. Ganciclovir, the internal
standard chosen by Kaisari et al. [71], has more structural
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similarities to the analytes than does fluconazole, which
was used in the method described by Yadav et al. [74]. Xu
et al. [73] presented a method for simultaneous quantifica-
tion of valganciclovir and ganciclovir in plasma. The lower
limit of quantification for valganciclovir was 0.004 mgL−1
which was even slightly lower than that one reported by
Yadav et al. [74], even though only 50 μL plasma was used
for protein precipitation.
Antibacterial drugs
TDM of aminoglycosides and glycopeptides is per-
formed routinely nowadays. This has helped to greatly
reduce the number of patients having the severe side
effects of these drugs. For all drugs which are clinically
used, immunoassays are available and enable rapid and
reliable quantification. For other antibiotic drugs, e.g.
drugs against tuberculosis, no immunoassays are avail-
able and, therefore, chromatographic methods have to be
applied to check a patient’s adherence to therapy or to
monitor drug levels in cases of suspected pharmacoki-
netic interactions.
Many methods published for quantification of antibac-
terial drugs still use HPLC with UV detection, e.g. for
quantification of linezolid [75–77], daptomycin [78],
tobramycin [79], or the simultaneous determination of
several antibiotic drugs [80]. Since 2000, five papers have
been published on use of LC–MS(–MS) for quantification
of tobramycin [81, 82] and vancomycin [83] specifically, or
methods for simultaneous quantification of several antibac-
terial drugs [84–86]. All the methods used protein precip-
itation for sample preparation [81, 82, 84, 86], except that
described by Zhang et al., for which SPE was used [83].
Concerning the selection of internal standards, the structural
analogue sisomycin was used in two methods [81, 82]. Lu
et al. [84] used one of the therapeutically used aminoglyco-
side antibiotic drugs (tobramycin) which may be used for
well controlled clinical studies but should not be used
routinely when analysing real clinical samples. Concerning
detection of the analytes, Lu et al. [84] described a
combination of nanospray ESI and Q-TOF mass spectrom-
etry. Data for precision and accuracy, and the analytical
range were presented convincingly. Unfortunately, the
authors only validated their assay for amikacin and did
not include any data on matrix effects or ion suppression.
The procedures published by de Velde et al. [85] and
Baietto et al. [86] were fully validated for all the
compounds included in the method, namely clarithromycin
and its metabolite and rifampicin and its metabolite [85],
and daptomycin, amikacin, gentamicin, and rifampicin [86].
Both authors also included matrix effects in their validation
process.
Concerning the quantification of tuberculostatic drugs,
the situation is the same as for the other antibacterial
drugs. Several methods using UV or diode array
detection have been reported [87–90]. In the last few
years four papers have been published describing the
quantification of tuberculostatic drugs, only, by LC–MS(–
MS). The drugs measured included rifampicin [91, 92],
isoniazid [92, 93], ethambutol [92–94], and pyrazinamid
[92, 94]. All methods used protein precipitation as
extraction method with a sample (plasma) volume ranging
from 50 to 100 μL. The method described by Song et al.
[92] included the determination of the four first-line drugs
for treatment of tuberculosis with an analytical range
covering trough and peak concentrations. Unfortunately
isoniazid, ethambutol, and pyrazinamide eluted close to
the void volume of the column. The authors then added
aminonicotinic acid as second internal standard which
coeluted with the three compounds and therefore under-
went the same ion suppression processes. They demon-
strated that the method was accurate and precise and
applied it to patients taking, mostly, four different tuber-
culostatic drugs without any problems. Nevertheless
special care must be taken if compound peaks elute close
to the void volume, and the addition of an internal
standard cannot always compensate for ion suppression
as the ionisation efficiency might be much better than for
the analyte (Table 3).
Antihelmintic drugs
TDM of antihelmintic drugs is most often done for
benzimidazoles, e.g. the active metabolite of albendazole.
Other compounds which are sometimes analysed are, e.g.,
ivermectin or praziquantel. For TDM of antihelmintic
drugs, two main techniques have been used: capillary
electrophoresis [95, 96] and HPLC. Only a few methods
using LC–MS(–MS) have been published [97–99]; notably,
two of the three were from the same research group
(Table 4). Perhaps because of the economic situation in
countries using antihelmintic drugs, methods using UV
detection [100, 101], sometimes in combination with
fluorescence detection [102], have been published.
Two of the published LC–MS(–MS) methods used
liquid–liquid extraction of a relatively large volume of
plasma (1 mL) with ESI detection in positive mode [97,
98]. The first paper of Bonato et al. [97] covered the
quantification of the two main metabolites of albendazole,
albendazole sulfoxide and albendazole sulfone, with an
analytical range of 5–2,500 μgL−1 for the first metabolite
and 0.5–250 μgL−1 for the second. In the second paper,
Bonato et al. [98] presented a method, which, besides the
two albendazole metabolites, also included praziquantel
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and its main metabolite, trans-4-hydroxypraziquantel. For
all the analytes, the analytical range was 5–2,500 μgL−1.
Matrix effects, an important factor lacking in the valida-
tion of the procedure reported by Bonato et al. 2003 [97]
was added to the validation procedure of the method from
the same authors in 2007 [98]. For determination of
ivermectin, Pereira et al. [99] published a method using a
semi-automated protein-precipitation approach, using ESI




The oldest antimalarial drug still in use, quinine, has a
favourable feature, namely its strong fluorescence upon
activation with UV light. This feature has been used for
detection of quinine and metabolites and other antimalarial
drugs in human samples, either with classical HPLC [103,
104] or with capillary–LC [105]. Several different extrac-
tion techniques were used for methods using HPLC with
UV detection for the quantification of antimalarial drugs:
liquid-phase microextraction [106], solid-phase microex-
traction [107], automated solid-phase extraction [108], and
extraction with restricted-access materials [109]. As sample
material, many methods use dried blood spots, either with
UV detection [110–113], or fluorescence detection [114].
Chromatographic methods for the quantification of
newer antimalarial drugs usually applied SRM mass
spectrometry as detection tool (Table 5). An LC–MS(–
MS) procedure enabling simultaneous determination of 14
antimalarial drugs and their metabolites in plasma was
recently published by Hodel et al. [115]. The method used
200 μL plasma, a fast protein precipitation procedure,
positive mode ESI, and SRM detection; the runtime was
21 min. The method was extensively validated, including a
check of the stability of endoperoxide-containing drugs in
haemolysed plasma. Nevertheless, a disadvantage of the
method could be that only two internal standards,
trimipramine-d3 and artemisinin (itself an antimalarial
drug), were used. Regarding the distribution of the retention
times in this multi-analyte procedure (approximately 4–
16 min), two internal standards with retention times of
8.8 min (trimipramine-d3) and 11.1 min (artemisinin)
would not be able to compensate for all fluctuations, e.g.
of the ionization efficiency, for all the analytes.
The newer substances, artemether and artesunate, on
which many pharmacokinetic trials have been performed,
dominate the picture of newly developed LC–MS(–MS)
methods for antimalarial drugs. For artemether, three LC–
MS(–MS) methods have been published since 2000,
including the method by Hodel et al. [115] discussed
earlier. In 2002, Souppart et al. [116] presented a method
for quantification of artemether and its main metabolite,
dihydroartemisinin, with liquid–liquid extraction of 0.5 mL
plasma and positive mode APCI, monitoring single
fragment ions for both analytes with the same mass-to-
charge ratio of 267. The analytical range was 5–200 μgL−1
for both analytes; evaluation of matrix effects was missing
from the validation study. The method was applied to a
pharmacokinetic interaction study. Huang et al. [117]
presented, in 2009, a method with a slightly wider
analytical range, 2–200 μgL−1 for artemether and dihy-
droartemisinin. The method used solid-phase extraction,
again 0.5 mL plasma, ESI in positive mode, and SRM,
monitoring of the transitions m/z 316→267 for artemether
and m/z 302→267 for dihydroartemisinin. In this method,
the runtime was 6 min, which is only one third of that for
the method by Souppart et al. [116]. The applicability of the
method was shown by analysing samples from healthy
volunteers taking artemether for three days.
For artesunate and its metabolite dihydroartemisinin, a total
of five LC–MS(–MS) methods, including the method by
Hodel et al. [115] discussed earlier, have been introduced
since 2000. Three of these methods used artemisinin as
internal standard [118–120], one used indomethacin [121].
The run times of the methods differed quite substantially,
from 7 min [121] to 21 min [118]. Also the analytical ranges
differed, with a lower limit of 1 μgL−1 for both analytes
[118] up to 25 μgL−1 for artesunate [120] and 10 μgL−1 for
dihydroartemisinin [119, 120]. The upper limit of quantifica-
tion was 3,200 μgL−1 for both analytes [119]. For extraction,
the sample volume required ranged from 50 μL [121] to
1 mL [120]. Naik et al. [118] used solid-phase extraction, the
others liquid–liquid extraction [119–121]. For ionization,
APCI [118, 120] and ESI [119, 121] were applied equally.
Accuracy and precision were comparable for all methods.
The quantification of artemisinin using artesunate as
internal standard was performed by Lindegardh et al. [122].
The method used a very small amount of sample with only
50 μL plasma. The analytical range of the method was
1.03–762 μgL−1.
For quantification of amodiaquine and its active metab-
olite N-desethylamodiaquine in whole blood, Chen et al.
[123] developed and validated a method using ion-pair
liquid chromatography. The analytical range of the method
was 0.15–100 μgL−1 for amodiaquine and 1.5–1,000 μg
L−1 for N-desethylamodiaquine. This method was also
applied to a pharmacokinetic study.
Others
Besides antimalarial drugs, TDM is used for a few other
antiprotozoal drugs only, the most important being metro-
nidazole, a nitroimidazole derivative. HPLC was mainly
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used for quantification of antiprotozoal drugs, with either
diode-array [124] or UV [125] detection. In the time period
considered for this review two papers have been published
describing quantification of antiprotozoal drugs by LC–MS
(–MS) (Table 6) [126, 127].
The LC–MS–MS method developed by Sagan et al.
[126] enabled determination of metronidazole and spira-
mycin I in plasma, saliva, and gingival crevicular fluid,
using liquid–liquid extraction of a 500-μL sample. Silva et
al. [127] presented a method for metronidazole only, and
for which less sample (250 μL) was needed for the liquid–
liquid extraction. The analytical range was also extended,
and ranged from 0.05–8 mgL−1 compared with 0.05–5 mg
L−1 for the method by Sagan et al. [126]; also, the run-time
was shortened by 50% to 5 min. Precision and accuracy of
both intra-day and inter-day assays were comparable. After
complete validation, the method of Silva et al. [127] was
applied to a bioequivalence study.
Conclusions
This paper illustrates the increasing role of LC–MS(–MS)
for measurement of anti-infective drugs. For each drug
category, methods have been published enabling quantifi-
cation of several drugs in a single run. Because most of the
drugs discussed in this article are not used in big patient
groups, this approach helps the laboratory to enable a short
turn-around-time also with low sample numbers for each
compound. Nevertheless it should not be forgotten that LC–
MS(–MS) methods need a very careful validation, taking
special care to minimise ion suppression and to select
appropriate internal standards.
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